'Incredibly Exciting': Diabetes Drug With CV Benefits
The FDA ' s recent addition of a cardiovascular indication for diabetes drug empagliflozin is a significant milestone in diabetes care, says Dr Anne Peters.
Source: Medscape Diabetes & Endocrinology Podcast - Category: Endocrinology Authors: Medscape Source Type: podcasts
More News: Cardiology | Cardiovascular | Diabetes | Empagliflozin | Endocrinology | Heart | Jardiance | Podcasts